CAS 1391712-60-9
:CEP-37440
Description:
CEP-37440, identified by its CAS number 1391712-60-9, is a chemical compound that has garnered attention in the field of medicinal chemistry. It is primarily recognized for its potential therapeutic applications, particularly in the context of neurological disorders. The compound exhibits a specific mechanism of action that may involve modulation of certain neurotransmitter systems, which is crucial for its efficacy in treating conditions such as anxiety or depression. CEP-37440 is characterized by its unique molecular structure, which contributes to its biological activity and selectivity. Additionally, it has undergone various preclinical studies to evaluate its pharmacokinetic properties, safety profile, and overall effectiveness. As with many investigational compounds, further research is necessary to fully understand its potential benefits and any associated risks. Overall, CEP-37440 represents a promising candidate in the ongoing search for effective treatments in neuropharmacology.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
CEP-37440
CAS:CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).Formula:C30H38ClN7O3Purity:98.86% - 99.98%Color and Shape:SolidMolecular weight:580.12CEP-37440
CAS:<p>CEP-37440 is a molecule with potential anti-cancer properties. It has been investigated in vitro and in vivo for its ability to inhibit the activity of kinases, which are enzymes that phosphorylate proteins on the cellular level. This drug has been shown to be cytotoxic against tumor cells and it does not show any adverse effects on normal cells. CEP-37440 has also been shown to have pharmacokinetic properties that allow it to be administered orally, making it an attractive candidate for clinical use.</p>Formula:C30H38ClN7O3Purity:Min. 95%Molecular weight:580.12 g/mol
